126 related articles for article (PubMed ID: 27645108)
21. The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years.
Gilsenan A; Harding A; Kellier-Steele N; Harris D; Midkiff K; Andrews E
Osteoporos Int; 2018 Oct; 29(10):2335-2343. PubMed ID: 29978254
[TBL] [Abstract][Full Text] [Related]
22. Anabolic therapies for osteoporosis.
Uihlein AV; Leder BZ
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
[TBL] [Abstract][Full Text] [Related]
23. Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data.
Gilsenan A; Midkiff K; Harris D; McQuay L; Hunter S; Kellier-Steele N; Andrews E
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1616-1626. PubMed ID: 32894794
[TBL] [Abstract][Full Text] [Related]
24. Teriparatide for severe osteoporosis.
Cappuzzo KA; Delafuente JC
Ann Pharmacother; 2004 Feb; 38(2):294-302. PubMed ID: 14742769
[TBL] [Abstract][Full Text] [Related]
25. The bone growth-stimulating PTH and osteosarcoma.
Whitfield JF
Medscape Womens Health; 2001 Oct; 6(5):7. PubMed ID: 11698929
[No Abstract] [Full Text] [Related]
26. Recombinant human parathyroid hormone.
Reeve J
BMJ; 2002 Feb; 324(7335):435-6. PubMed ID: 11859030
[No Abstract] [Full Text] [Related]
27. [Parathyroid hormone for osteroporsis: why and who to treat?].
Ferrari S; Rizzoli R
Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
[TBL] [Abstract][Full Text] [Related]
28. [PTH preparations].
Fukumoto S
Nihon Rinsho; 2015 Oct; 73(10):1696-700. PubMed ID: 26529932
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid hormone: new drug. Osteoporosis: just a teriparatide me-too.
Prescrire Int; 2008 Jun; 17(95):102. PubMed ID: 18623910
[TBL] [Abstract][Full Text] [Related]
30. Comments on Initial experience with teriparatide in the United States.
Harper KD; Krege JH; Marcus R; Mitlak BH
Curr Med Res Opin; 2006 Oct; 22(10):1927. PubMed ID: 17022851
[No Abstract] [Full Text] [Related]
31. [A new osteoporosis drug. Recombinant parathyroid hormone rebuilds bone].
MMW Fortschr Med; 2003 Jun; 145(25):53. PubMed ID: 12891857
[No Abstract] [Full Text] [Related]
32. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.
Migliore A; Broccoli S; Massafra U; Bizzi E; Frediani B
Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of osteoporosis with PTH].
Takeuchi Y
Clin Calcium; 2014 Jun; 24(6):893-902. PubMed ID: 24870841
[TBL] [Abstract][Full Text] [Related]
34. [New approved drugs for osteoporosis in Japan].
Endo I; Matsumoto T
Clin Calcium; 2012 Jun; 22(6):870-6. PubMed ID: 22653027
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis.
Chen LX; Zhou ZR; Li YL; Ning GZ; Zhang TS; Zhang D; Feng SQ
PLoS One; 2015; 10(5):e0128032. PubMed ID: 26010450
[TBL] [Abstract][Full Text] [Related]
36. [Teriparatide:benefit and safety for bone disease in CKD patients undergoing hemodialysis].
Yamamoto S; Ei I; Narita I
Clin Calcium; 2016 Sep; 26(9):1301-7. PubMed ID: 27561345
[TBL] [Abstract][Full Text] [Related]
37. Initial experience with teriparatide in the United States.
Gold DT; Pantos BS; Masica DN; Misurski DA; Marcus R
Curr Med Res Opin; 2006 Apr; 22(4):703-8. PubMed ID: 16684431
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of early bone histomorphometric effects of parathormone and alendronate in osteoporotic women].
Arlot M; Roux JP; Portero N; Boivin G; Meunier PJ
Rev Med Suisse Romande; 2004 Feb; 124(2):91-2. PubMed ID: 15095621
[TBL] [Abstract][Full Text] [Related]
39. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.
Vahle JL; Sato M; Long GG; Young JK; Francis PC; Engelhardt JA; Westmore MS; Linda Y; Nold JB
Toxicol Pathol; 2002; 30(3):312-21. PubMed ID: 12051548
[TBL] [Abstract][Full Text] [Related]
40. Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis.
Borgström F; Ström O; Marin F; Kutahov A; Ljunggren O
J Med Econ; 2010; 13(3):381-92. PubMed ID: 20604678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
